Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors-Reference-Cited by-同舟云学术

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

Published:2015-10 Issue:10 Volume:17 Page:1057-1065
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Pitt Bertram¹,Bakris George L.²,Bushinsky David A.³,Garza Dahlia⁴,Mayo Martha R.⁴,Stasiv Yuri⁴,Christ‐Schmidt Heidi⁵,Berman Lance⁴,Weir Matthew R.⁶

Affiliation:

1. Department of Medicine University of Michigan School of Medicine 1500 East Medical Center Drive Ann Arbor MI 48109‐0366 USA

2. ASH Comprehensive Hypertension Center Division of Endocrinology, Diabetes, and Metabolism Department of Medicine The University of Chicago Medicine Chicago IL USA

3. University of Rochester School of Medicine Rochester NY USA

4. Relypsa, Inc. Redwood City CA USA

5. Statistics Collaborative, Inc. Washington DC USA

6. Division of Nephrology, Department of Medicine University of Maryland School of Medicine Baltimore MD USA

Funder

Relypsa, Inc.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.402

Reference27 articles.

1. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

2. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

3. Colonic potassium handling

4. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

5. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease;Kidney Disease Outcomes Quality Initiative (K/DOQI);Am J Kidney Dis,2004

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Trial Patiromer on Efficacy to Reduce Episodic Hyperkalemia in Patients with ESKD Treated With Hemodialysis;Kidney International Reports;2024-08

2. Protocol for systematic review and meta-analysis for randomized clinical trials on patiromer efficacy and safety in subjects with heart failure;PHARM PRACT-GRANADA;2024

3. Real-world management of chronic and postprandial hyperkalemia in CKD patients treated with patiromer: a single-center retrospective study;Journal of Nephrology;2024-02-06

4. Randomised, blinded, cross-over evaluation of the palatability of and preference for different potassium binders in participants with chronic hyperkalaemia in the USA, Canada and Europe: the APPETIZE study;BMJ Open;2024-02

5. Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis;European Journal of Internal Medicine;2024-01